BOSTON—Extended-duration prophylactic therapy with letermovir (Prevymis, Merck) may reduce cytomegalovirus (CMV) reactivation in allogeneic hematopoietic stem cell […]
Posts in Hematologic Malignancies
© 2024 Oncologycongressnews. Mediahuset i Göteborg AB